Structures by: Nisar M.
Total: 19
11-Azaart
C15H23NO4
CrystEngComm (2018) 20, 9 1205
a=11.71759(15)Å b=11.71759(15)Å c=9.48728(13)Å
α=90° β=90° γ=120°
11-Aza:Ben
C15H23NO4,C7H6O2
CrystEngComm (2018) 20, 9 1205
a=9.64312(19)Å b=9.3622(2)Å c=22.8165(4)Å
α=90° β=90.9437(18)° γ=90°
11-Aza:Sal
C15H23NO4,C7H6O3
CrystEngComm (2018) 20, 9 1205
a=9.79451(14)Å b=9.30687(13)Å c=11.51291(16)Å
α=90° β=92.3070(12)° γ=90°
11-Aza:Succ
2(C15H23NO4),C4H6O4
CrystEngComm (2018) 20, 9 1205
a=17.9674(7)Å b=10.3025(4)Å c=9.3723(7)Å
α=90° β=90° γ=90°
11-Aza:L-Mal
2(C15H23NO4),C4H6O5
CrystEngComm (2018) 20, 9 1205
a=17.7811(3)Å b=10.3174(2)Å c=9.49693(15)Å
α=90° β=90° γ=90°
11-Aza:Pim
2(C15H23NO4),C7H12O4
CrystEngComm (2018) 20, 9 1205
a=17.5836(7)Å b=10.3594(4)Å c=9.9524(3)Å
α=90° β=90° γ=90°
11-Aza:D-Mal
2(C15H23NO4),C4H6O5
CrystEngComm (2018) 20, 9 1205
a=10.43733(12)Å b=18.04445(19)Å c=18.6345(2)Å
α=90° β=90° γ=90°
11-Aza:D-Man
C15H23NO4,C8H8O3
CrystEngComm (2018) 20, 9 1205
a=10.00907(10)Å b=10.09992(10)Å c=20.9254(2)Å
α=90° β=90° γ=90°
Oroxylin A
C16H12O5
Acta Crystallographica Section C (2020) 76, 5 490-499
a=3.8224(2)Å b=19.5339(7)Å c=16.5360(6)Å
α=90° β=91.604(4)° γ=90°
Wogonin Monohydrate
C16H12O5,H2O
Acta Crystallographica Section C (2020) 76, 5 490-499
a=4.64835(6)Å b=16.4123(2)Å c=18.3290(3)Å
α=90° β=90° γ=90°
5,7-Dihydroxy-8-methoxy-2-phenyl-4<i>H</i>-chromen-4-one 1.25-hydrate
C16H12O5,1.25(H2O)
Acta Crystallographica Section C (2020) 76, 5 490-499
a=4.39382(9)Å b=18.7848(3)Å c=16.8308(3)Å
α=90° β=96.5918(19)° γ=90°
11-Azaartemisinin--<i>trans</i>-cinnamic acid (1/1)
C15H23NO4,C9H8O2
Acta Crystallographica Section C (2018) 74, 6
a=9.5552(4)Å b=10.3175(5)Å c=11.9645(6)Å
α=91.085(4)° β=110.515(4)° γ=93.998(3)°
11-Azaartemisinin--maleic acid (1/1)
C15H23NO4,C4H4O4
Acta Crystallographica Section C (2018) 74, 6
a=9.62162(12)Å b=10.40235(11)Å c=19.6935(2)Å
α=90° β=90° γ=90°
11-Azaartemisinin--maleic acid (2/1)
2(C15H23NO4),C4H4O4
Acta Crystallographica Section C (2018) 74, 6
a=9.78850(10)Å b=9.99650(10)Å c=33.7661(4)Å
α=90° β=90° γ=90°
11-Azaartemisinin--fumaric acid (1/1)
2(C15H23NO4),C4H4O4
Acta Crystallographica Section C (2018) 74, 6
a=9.57929(11)Å b=10.05214(16)Å c=17.7765(2)Å
α=90° β=96.4731(11)° γ=90°
4-Hydroxy-3-(3-methoxybenzoyl)-2-[(3-methoxybenzoyl)methyl]-2<i>H</i>-1,2- benzothiazine 1,1-dioxide
C25H21NO7S
Acta Crystallographica Section E (2010) 66, 9 o2314-o2315
a=10.3169(2)Å b=10.6923(3)Å c=11.6867(3)Å
α=115.5965(11)° β=105.8041(14)° γ=97.6128(13)°
4-({[(<i>E</i>)-Pyridin-3-ylmethylidene]amino}methyl)cyclohexanecarboxylic acid
C14H18N2O2
Acta Crystallographica Section E (2011) 67, 5 o1058
a=12.7580(6)Å b=11.2504(6)Å c=18.8088(7)Å
α=90° β=94.720(2)° γ=90°
4,5,9,9,13,19,20-Heptamethyl-23-oxo-24- oxahexacyclo[15.5.2.0^1,18^.0^4,17^.0^5,14^.0^8,13^]tetracos- 15-en-10-yl acetate
C32H48O4
Acta Crystallographica Section E (2013) 69, 4 o573
a=13.7309(8)Å b=6.9177(4)Å c=14.8539(9)Å
α=90° β=90.943(2)° γ=90°
Negletein
C16H12O5
Acta Crystallographica Section C (2020) 76, 5 490-499
a=9.78509(13)Å b=15.8032(2)Å c=8.33104(11)Å
α=90° β=91.3453(11)° γ=90°